What we do Molbio Diagnostics is an innovative point-of-care diagnostics company focusing on rapid, accurate, and cost-effective healthcare tech for infectious and non-communicable diseases. |
Founded in 2,000 |
Market share Leading provider of decentralized PCR diagnostics in India with emerging international presence. |
Problem solved Expands access to quick and affordable disease diagnosis even in resource-limited areas via portable, battery-operated devices. |
Top clients or who we serve Public health programs, diagnostic laboratories, private and public hospitals globally (B2B). |
Key management - |
Our journey and innovations Founded 2000; developed Truenat PCR platform in 2015; acquired Prognosys Medical (radiology) 2023 and stake in OptraScan (digital pathology) 2024. |
Where we operate India (major manufacturing facilities) and international markets including USA. |
Top products or what we offer Truenat rapid PCR diagnostic platform, radiology equipment, chip-based diagnostic devices, reagents, digital pathology scanners. |
Top brands Truenat - novel POC PCR platform, leading in molecular diagnostics; Prognosys and OptraScan product lines expanding imaging and pathology portfolio. |
Raw materials needed - |
Raw materials supplier - |
Recurring vs cyclical contribution Primarily recurring revenues from device sales, reagents, and services with some cyclical project-based orders. |
Our industry position Innovator and market leader in decentralized molecular diagnostics in India with growing footprint internationally. |
Financial highlights FY2023 Revenue Rs 1445.69 Cr, Net Profit Rs 166.59 Cr, showing solid profitability and scale. |
Geographical revenue split 91% revenue from India, 9% from international markets as of FY2023. |
Order book - |
Whats driving growth Growth driven by expanding POC diagnostics adoption, acquisitions, and product diversification across imaging and pathology. |
Our future plans Planned Rs 200 Cr equity raise via IPO to fund expansion and new product development. |
Our green promise - |
Our people and values - |
Key challenges ahead Competition from global diagnostics companies and technological innovation pace. |
Interesting facts Truenat platform operates on battery, uniquely enabling diagnostics in low-resource settings. |
Risks and strategy Risk mitigation via diversified product portfolio, acquisitions, and global expansion strategy. |
